Medical Equipment

Projected Growth of the Global Drug Screening Market to Reach $16.86 Billion by 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the drug screening market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Drug Screening Market By The End Of 2029?

The drug screening market has seen swift growth in its size over recent years. It is projected to increase from $8.57 billion in 2024 to $9.72 billion in 2025, achieving a compound annual growth rate (CAGR) of 13.3%. This expansion during the historic period can be ascribed to factors including pharmaceutical drug testing, advancements in healthcare and clinical diagnostics, efforts in substance abuse treatment, investments in research and development, and the growing usage of drug testing kits and devices.

The drug screening market is anticipated to experience substantial growth over the next few years. It is expected to expand to $16.86 billion by 2029, achieving a compound annual growth rate (CAGR) of 14.8%. This projected increase during the forecast period can be attributed to the legalization of cannabis and the ongoing opioid crisis, a rise in sports events, the development of point-of-care and rapid testing solutions, changes in drug policies and regulations, the expansion of workplace wellness and health programs, and international market outreach. Key trends expected in the forecast timeframe include advanced drug detection technologies, the rise of telemedicine and remote testing, investments in research and development, the introduction of innovative drug testing kits and devices, and general technological progress in testing methods.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp

Which Business Drivers Are Underpinning The Growth Of The Drug Screening Market?

An anticipated increase in drug and alcohol consumption is projected to drive the expansion of the drug screening market in the coming years. Drug addiction is a condition that impacts an individual’s brain and behavior, leading to an inability to manage the intake of legal or illegal drugs or medications. Substances like alcohol, marijuana, and nicotine are also classified as drugs. As addiction to drugs and alcohol rises, the likelihood of developing diseases also increases, thereby stimulating the demand for drug screening. For instance, in 2022, the worldwide issue of drug and alcohol consumption remained a significant concern. According to the National Survey on Drug Use and Health (NSDUH), 13.5% of Americans aged 12 and over reported drug use in the last month, indicating a 3.8% year-over-year increase. Moreover, the report further stated that 59.277 million, or 21.4%, of people aged 12 and over had used illegal drugs or misused prescription drugs within the previous year. The effects of the pandemic also exacerbated drug risks, with cannabis intake among youth increasing by as much as four times in various parts of the world. Consequently, the escalating consumption of drugs and alcohol is fueling the growth of the drug screening market throughout the forecast period.

What Are The Principal Segment Types In The Drug Screening Market?

The drug screeningmarket covered in this report is segmented –

1) By Products: Rapid Testing Devices, Consumables, Other Products

2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types

3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

Subsegments:

1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips

2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards

3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions

How Are Industry Trends Steering The Expansion Of The Drug Screening Market?

The introduction of innovative products is a significant trend gaining traction in the drug screening market. Key players in the drug screening market are concentrating on developing and launching advanced products to satisfy rapidly expanding industry demand and reinforce their market position. Moreover, the COVID-19 pandemic prompted a sudden alteration in the drug screening approach, which transformed screening methodologies and spurred companies towards innovation and the creation of new products. Companies are dedicated to developing novel products, such as more effective drug tests that can be extensively utilized by laboratories. For instance, in September 2022, Sysmex Corporation, a Japan-based healthcare company, unveiled the UF-1500 Fully Automated Urine Particle Testing Analyzer, a new product intended for urine sediment testing and screening. The UF-1500 incorporates the superior functionality and ease of use found in the UF-5000 Fully Automated Urine Particle Analyzer, Sysmex’s leading model in urine sediment testing, while achieving a more compact form compared to the previous model.

Which Companies Are Contributing Significantly To The Drug Screening Market Growth?

Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Which Region Offers The Most Opportunity For Drug Screening Market Expansion?

North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=6369&type=smp

Browse Through More Reports Similar to the Global Drug Screening Market 2025, By The Business Research Company

Data Protection As A Service Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/data-protection-as-a-service-global-market-report

Cloud Security Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cloud-security-global-market-report

Application Security Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/application-security-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795